Indoxyl Sulfate Induces Oxidative Changes in Plasma and Hemolysate

Area of Science:

• Nephrology
• Biochemistry
• Oxidative Stress Research

Background:

• Chronic kidney disease (CKD) is characterized by the accumulation of toxic metabolic products.
• Indoxyl sulfate (IS) is a protein-bound uremic toxin implicated in CKD pathogenesis.
• IS is known to induce oxidative stress.

Purpose of the Study:

• To investigate the impact of indoxyl sulfate (IS) on oxidative stress markers in plasma and erythrocytes.
• To determine if IS contributes to oxidative damage in components relevant to CKD progression.

Main Methods:

• In vitro evaluation of IS effects on plasma and hemolysate.
• Measurement of oxidative stress parameters, including total antioxidant capacity, catalase, and superoxide dismutase activity.

Main Results:

• Indoxyl sulfate (IS) induced significant oxidative damage to both plasma and hemolysate components.
• A decrease in total antioxidant capacity and altered enzyme activity (catalase, superoxide dismutase) were observed.
• Oxidative stress parameters showed greater changes in hemolysate compared to plasma following IS treatment.

Conclusions:

• Indoxyl sulfate (IS) directly causes oxidative damage to erythrocytes and plasma.
• Increased IS concentrations in CKD patients may impair erythrocyte function and survival.
• These findings suggest IS contributes to CKD progression through oxidative mechanisms affecting red blood cells.